The goals of treatment is to eliminate HCV infection, stop or reverse histological changes,
reduce the risk of hepatocellular carcinoma development and transmission of the infection to …

Chronic infection with hepatitis C virus (HCV) is one of the leading causes of liver disease
globally, affecting approximately 71 million people. The majority of them are infected with …

BACKGROUND Nearly 290000 patients with chronic hepatitis C die annually from the most
severe complications of the disease. One of them is liver cirrhosis, which occurs in about …

Hepatitis C infection is one of the main reasons for liver cirrhosis and hepatocellular
carcinoma. In recent years, more and more is being heard about extrahepatic manifestations …

There is still limited data available from real-world experience studies on the pangenotypic
regimens in patients with genotype (GT) 3 hepatitis C virus (HCV) infection and liver …

The aim of the EpiTer‐2 study was to analyse patient characteristics and their medication for
HCV infection in Poland at the beginning of the interferon‐free era. Analysis of data of HCV …

BACKGROUND The revolution in treatment of patients with chronic hepatitis C virus (HCV)
infection dates back to the introduction of direct-acting antivirals (DAAs). The increase in …

Abstract Purpose Hepatitis C virus (HCV) infection remains a major health problem and one
of the leading causes of chronic liver disease worldwide. The purpose of this paper was to …

Clinical characteristics and antiviral therapy in patients infected with hepatitis C virus in the
interferon ‑free era Page 1 ORIGINAL ARTICLE HCV patients and therapy characteristics 1 …

The aim of the study is to analyze treatments available for patients infected with genotype
(G) 3 hepatitis C virus (HCV) in Poland at the beginning of the interferon (IFN)-free era and …